Joaquin Duato sold $22.5M of Johnson & Johnson (JNJ)

Executed Aug 22 2025, disclosed Aug 25 2025, 3 days later.

Value, as filed

$22.5M

125,824 sh × $179.21

Executed

Aug 22 2025

the trade date, as filed

Disclosed

Aug 25 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JD Joaquin Duato CEO and Chairman of the Board profile →

Joaquin Duato (CEO and Chairman of the Board) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Johnson & Johnson (JNJ). The largest single filing was $32.2M of JNJ (123,291 sh across 2 lots, as filed), executed Aug 13.

The name

JNJ Johnson & Johnson JNJ · Healthcare · 86 filings in 24 months ticker →

Healthcare · Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joaquin Duato in JNJ

JNJSALE Johnson & Johnson $32.2M
123,291 sh across 2 lots
Exec Aug 13
Filed Aug 14 · 4:35 PM ET JNJSALE Johnson & Johnson $12.5M
48,480 sh across 2 lots
Exec Aug 5
Filed Aug 7 · 5:50 PM ET JNJSALE Johnson & Johnson $22.1M
100,000 sh across 2 lots
Exec Jan 26
Filed Jan 28 · 5:30 PM ET